SUTRO BIOPHARMA, INC. (STRO) Operating Lease, Liability USD 2021 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Sutro Biopharma, Inc. quarterly Operating Lease, Liability history and growth rate from 2021 to 2024.
Sutro Biopharma, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $28.1 M, a 15.8% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$28.1 M	-$5.25 M	-15.8%	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$29.6 M	-$4.59 M	-13.4%	Dec 31, 2023	10-K	2024-03-25
Q3 2023	$31 M	-$2.63 M	-7.81%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$32.5 M	-$729 K	-2.2%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$33.3 M	+$610 K	+1.87%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$34.2 M	+$1.9 M	+5.88%	Dec 31, 2022	10-K	2023-03-30
Q3 2022	$33.7 M	+$151 K	+0.45%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$33.2 M			Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$32.7 M			Mar 31, 2022	10-Q	2022-05-09
Q4 2021	$32.3 M			Dec 31, 2021	10-K	2022-02-28
Q3 2021	$33.5 M			Sep 30, 2021	10-Q	2021-11-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.